Induction of prosurvival molecules during treatment: Rethinking therapy options for photodynamic therapy

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 10, Issue SUPP.2, 2012, Pages

  Gomer, Charles J ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CASPASE 9; CELECOXIB; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; GELDANAMYCIN; HEMATOPORPHYRIN DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIX METALLOPROTEINASE; PHOTOFRIN; PRINOMASTAT; PROSTAGLANDIN E2; RETASPIMYCIN; STROMAL CELL DERIVED FACTOR 1ALPHA; SURVIVIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; HUMAN; IONIZING RADIATION; KAPOSI SARCOMA; LEARNING; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PROTEIN EXPRESSION; RETINOBLASTOMA; TUMOR MICROENVIRONMENT; TUMOR RECURRENCE; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 84871237245     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2012.0172     Document Type: Article

References (10)

1. Gomer CJ, Doiron DR, Jester JV, et al. Hematoporphyrin derivative photoradiation therapy for the treatment of intraocular tumors: examination of acute normal ocular tissue toxicity. Cancer Res 1983;43:721-727. (Pubitemid 13193871)
2. Gomer CJ, Doiron DR, White L, et al. Hematoporphyrin derivative photoradiation induced damage to normal and tumor tissue of the pigmented rabbit eye. Curr Eye Res 1984;3:229-237. (Pubitemid 14163882)
3. Chaudhury S, Welch TR, Blagg BS. Hsp90 as a target for drug development. ChemMedChem 2006;1:1331-1340.
4. Ferrario A, Gomer CJ. Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model. J Environ Pathol Toxicol Oncol 2006;25:251-259. (Pubitemid 43341245)
5. Ferrario A, Gomer CJ. Targeting the 90 kDa heat shock protein improves photodynamic therapy. Cancer Lett 2010;28:188-194.
6. Gomer CJ, Ferrario A, Luna M, et al. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg Med 2006;38:516-521.
7. Ferrario A, Lim S, Xu F, et al. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib. Cancer Lett 2011;304:33-40.
8. Ferrario A, Chantrain CF, von Tiehl K, et al. The matrix metalloproteinase inhibitor prinomastat enehances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res 2004;64:2328-2332. (Pubitemid 38523882)
9. Osiecka B, Jurczyszyn K, Symonowicz K, et al. In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester. Cell Mol Biol Lett 2010;15:630-650.
10. Ferrario A, Rucker N, Wong S, et al. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res 2007;67:4989-4995. (Pubitemid 46910208)